Japanese medical technology firm CureApp is getting 7 billion yen ($51.4 million) in investment from global investment firm Carlyle as part of their strategic partnership.
Carlyle is taking a minority stake in the company, which has so far raised 13.4 billion yen ($98 million) in capital funding.
Founded in 2014, CureApp is involved in the research and development of prescription and non-...
